China poses increasing security risk as US biotech innovation edge erodes

Summary

Article discusses concerns about the U.S. biotech industry's competitive position relative to China, noting that China is surpassing America in biomedical research and clinical trials development. No specific company announcements, trial data, or regulatory decisions are detailed.